IOVA - Iovance Biotherapeutics, Inc.

Exchange: NASDAQ

IOVA - Iovance Biotherapeutics, Inc.

Exchange: NASDAQ
#6324()/7534

Fri 19'th Oct 2018

PERIOD 2018-07-20 - 2018-10-19
CHANGE -9.43%
PRICE $9.89
VOLUME
Buy
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Request Prediction
0.00%
Predict

Iovance Biotherapeutics, Inc. Stock Analysis

Technical stock analysis for Fri 19'th Oct 2018

Sell candidate since 2018-10-17 Loss -9.10%
Shorts 6.41% ( 2018-09-28 )
Cash 163.4 mill
Loans n/a
Beta 2.23
ROA -49.76

Iovance Biotherapeutics, Inc. fell by -9.43% in the last day from $10.92 to $9.89 The price has fallen in 6 of the last 10 days and is down by -14.67% for this period. Volume has increased in the last day by 0.12 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.44 million shares bought and sold for approximately $14.27 million.

Trend

Iovance Biotherapeutics, Inc. lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $9.15 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -22.32% during the next 3 months and, with 90% probability hold a price between $7.11 and $11.93 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Iovance Biotherapeutics, Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $10.78 and $12.47. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday October 16, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 43 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Price: $9.89 Resistance: $10.69

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.22 between high and low, or 12.39%. For the last week, the stock has had a daily average volatility of 8.86%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Iovance Biotherapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Sell Candidate

Click for Top 5 Sell Candidates
IOVA $9.89 $-1.03(-9.43%)
IOVA is down $1.03 today, but where's it headed in November?
Zacks Investment Research is releasing its prediction for IOVA based on the 1-3 month system that more than doubles the S&P 500.

Click here – the IOVA analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL